LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

Strona główna・Stock List・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Closed

SectorHealthcare

1.23 1.65

Buy

Price update 19 maj 2026, 19:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.2

Max

1.34

Key metrics

By Trading Economics

Income

49M

3.8M

Employees

112

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+268.85% upside

Dividends

By Dow Jones

Next Earnings

11 sie 2026

Market Stats

By TradingEconomics

Market Cap

989K

98M

Previous open

-0.42

Previous close

1.23

Technical Score

By Trading Central

Confidence

Bullish Evidence

1.76 / 1.94 Support & Resistance

Inovio Pharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 gru 2025, 15:54 UTC

Major Market Movers

Inovio Shares Drop After FDA Says No Plans to Discuss INO-3107 Application

DJ

Read

Peer Comparison

Price change

Inovio Pharmaceuticals Inc Forecast

Price Target

By TipRanks

268.85% upside

12 Months Forecast

Average 4.5 USD  268.85%

High 6 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Based on 2 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.76 / 1.94Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

No Evidence

There are no events.

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,018.6

↑ +3.3%

JNJ

Johnson and Johnson

229.93

↑ +0.53%

ABBV

AbbVie Inc

213.62

↑ +1.94%

UNH

UnitedHealth Group Inc

389.29

↓-0.09%

AZN

AstraZeneca PLC

184.71

↑ +0.4%
help-icon Live chat